High flow nasal cannula Market Report 2026

High flow nasal cannula Market Overview

• High flow nasal cannula market size has reached to $6.22 billion in 2025 • Expected to grow to $9.64 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Surging Demand For High-Flow Nasal Cannulas Amidst Rising Asthma And COPD Cases • Market Trend: Innovative Respiratory Solutions With The Airvo 2 Device In High-Flow Nasal Therapy • North America was the largest region in 2025.

What Is Covered Under High flow nasal cannula Market?

High-flow nasal cannula (HFNC) is a medical device used to deliver a high flow of heated and humidified oxygen-enriched air to patients with respiratory conditions. It consists of a lightweight tube connected to a machine that regulates the flow of air and oxygen. The cannula, which is placed in the patient's nostrils, delivers a continuous stream of warm and moistened air at a higher flow rate than traditional oxygen therapy methods. The main types of high-flow nasal cannulas are air or oxygen blenders, nasal cannulas, active humidifiers, single-heated tubes, and others. Air-oxygen blenders are medical devices that combine air and oxygen to administer a precise combination of oxygen and air to patients suffering from breathing problems or undergoing anesthesia. The various applications include acute respiratory failure, chronic obstructive pulmonary disease (COPD), carbon monoxide toxicity, bronchiectasis, sleep apnea, and others. These are sold through various sales channels such as direct channels, and are used by various end-users such as hospitals and clinics, ambulatory care centers, long-term care centers, and others.

What Is The High flow nasal cannula Market Growth Forecast?

The high flow nasal cannula market size is expected to see strong growth in the next few years. It will grow to $9.64 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing use of hfnc in home care settings, rising demand for portable respiratory support devices, expansion of respiratory care services, growing focus on early intervention therapies, increasing technological advancements in airflow and humidification systems. Major trends in the forecast period include increasing adoption of advanced heated humidification systems, rising use of hfnc in acute care settings, growing preference for non-invasive oxygen therapy, expansion of portable and home-based hfnc solutions, enhanced focus on patient comfort and compliance.

Global High flow nasal cannula Market Segmentation

1) By Type: Air Or Oxygen Blenders, Nasal Cannulas, Active Humidifier, Single Heated Tube, Other Types 2) By Application: Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Carbon Monoxide Toxicity, Bronchiectasis, Sleep Apnea, Other Applications 3) By Sales Channel: Direct Channel, Distribution Channel 4) By End-User: Hospitals and clinics, Ambulatory care centers, Long-term care centers, Other End-Users Subsegments: 1) By Air or Oxygen Blenders: Manual Oxygen Blenders, Digital Oxygen Blenders 2) By Nasal Cannulas: Adult Nasal Cannulas, Pediatric Nasal Cannulas 3) By Active Humidifier: Heated Active Humidifiers, Non-Heated Active Humidifiers 4) By Single Heated Tube: Single Heated Tubes For Adult Use, Single Heated Tubes For Pediatric Use 5) By Other Types: Disposable High Flow Nasal Cannulas, Non-Invasive Ventilation (NIV) Interfaces

What Is The Driver Of The High flow nasal cannula Market?

The rise in asthma and chronic obstructive pulmonary disease (COPD) incidence is expected to propel the growth of the high-flow nasal cannula market going forward. Asthma is a disorder in which the airways in the lungs constrict and swell, and excess mucus is produced. chronic obstructive pulmonary disease (COPD) refers to a set of lung illnesses that make breathing difficult and worsen over time. High-flow nasal cannula has the potential to increase PO2 while minimizing HR and RR and acts as a viable treatment option for individuals suffering from severe bronchial Asthma worsened by respiratory failure. High flow nasal cannula helps address rising asthma and COPD cases by improving oxygenation and reducing respiratory distress in affected patients. For instance, in December 2023, according to a research study published by JAMA Network Open, a medical journal by the American Medical Association, the global burden of chronic obstructive pulmonary disease (COPD) projected that the cases worldwide could reach nearly 600 million by 2050, marking a 23% increase in prevalence. Therefore, the rise in asthma and chronic obstructive pulmonary disease (COPD) incidence is driving the high-flow nasal cannula market.

Key Players In The Global High flow nasal cannula Market

Major companies operating in the high flow nasal cannula market are Air Liquide Medical Systems Pvt. Ltd., Becton Dickinson and Company, Koninklijke Philips N.V., ResMed Inc., Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Medical Dynamics Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical Inc., Vyaire Medical Inc., DeVilbiss Healthcare LLC, Armstrong Medical Ltd, Vapotherm Inc., SunMed LLC, Medin Medical Innovations GmbH, MEK-ICS Co. Ltd., Narang Medical Limited, Breas Medical AB, Bio-Med Devices Inc., Flexicare Medical Ltd., Fairmont Medical Products Pty Ltd, Besmed Health Business Corp., Löwenstein GmbH & Co. KG, Great Group Medical Co. Ltd., TNI Medical AG, Guangdong Pigeon Medical Apparatus Co.LTD, BLS Systems Limited

Global High flow nasal cannula Market Trends and Insights

Major companies operating in the high-flow nasal cannula market are focusing on advanced products like the SoftFlow High-Flow Nasal Cannula to provide their existing consumers. The softFlow High-Flow Nasal Cannula is a breathing assistance device that uses a nasal cannula to give warm, humidified, oxygen-enriched oxygen to patients. For instance, in 2024, Fisher & Paykel Healthcare, a News Zealand-based manufacturer, and marketer of products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea, launched the Airvo 2 device which is a part of the Optiflow Nasal High Flow Therapy system. It delivers heated, humidified air and oxygen at high flow rates, which helps improve oxygenation and reduce the work of breathing for patients with COVID-19 and other respiratory conditions. Its optimal humidity levels maintain mucociliary function and reduce airway dryness, enhancing patient comfort. Additionally, the device is easy to set up and use, making it suitable for various hospital settings and improving clinical outcomes.

What Are Latest Mergers And Acquisitions In The High flow nasal cannula Market?

In March 2024, Onymos, a US-based developer of a Features-as-a-Service platform, entered into a partnership with Vapotherm, Inc. for an undisclosed amount. With this partnership, Onymos aims to help Vapotherm build a secure, end-to-end Internet of Medical Things (IoMT) platform to enhance remote device connectivity, data visualization, and device management for the HVT 2.0 system and future respiratory care products. Vapotherm, Inc. is a US-based medical technology company specializing in high-velocity respiratory therapy systems, such as high flow nasal cannulas.

Regional Outlook

North America was the largest region in the high flow nasal cannula market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the High flow nasal cannula Market?

The high-flow nasal cannula (HFNC) market consists of sales of flow generators, oxygen blenders, nasal prongs, and humidifiers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.